Tuesday, September 18, 2012

Meso Empowerment Exclusive: Dr. Cameron shares his brilliant insights on breakthrough moments at IMIG Conference in Boston or, Galileo is Smiling

Dr. Robert Cameron
iMig 2012
Dr. Robert Cameron, thoracic surgeon and mesothelioma specialist, was kind enough to provide us with his tweets as he attended the recent IMIG conference in Boston. His “boots on the ground” tweets were simply too compelling to leave alone so we followed up and asked him to elaborate

If you’re reading this, you’re no doubt aware of Dr. Cameron’s pioneering efforts to re-introduce “rationality” to the macho “bigger is better” mentality that unfortunately has tended to dominate meso surgery in the US. Although his pleurectomy/decortication (P/D) model is now becoming not only accepted but strongly endorsed, it wasn’t always this way.

I remember vividly at a meeting among surgeons 12 years ago where his fellow surgeons literally shussed Dr. Cameron when he tried to speak up against powerful, East Coast-driven forces who decreed that their big gnarly “extra-pleural pneumonectomy” (EPP) was as unassailable as a papal decree. For years, Dr. Cameron toiled away, mainly in the dark, while the spotlight remained brightly fixed on the “curative” EPP. But he never lost faith.  Like so many myth busters of lore (Galileo comes to mind), Dr. Cameron’s belief that removing the tumor and sparing the lung was the only rational way.

I can’t speak for Dr. Cameron, but for this cancer warrior, it feels good that his brethren have finally embraced the P/D on which Dr. Cameron based his career and his passion.

Here’s a few of the good doctor’s tweets and the follow up.

Enjoy the read and keep questioning, searching, learning and leaning towards the light.

*   *   *   *   *  

IMIG 2012: for the future of treatment of mesothelioma: the future is clearly immunotherapy!

Why is Dr. Cameron so optimistic? Let’s ask.

Dr. Cameron: Although we are only just now learning how to harness the power of immunotherapy, there is already evidence from decades ago that something as simple as stimulation with IL-2 into the pleural space can result in survivals that have rivaled "trimodality therapy" with median survivals as long as 28 months.

Furthermore, the immune system when it does work has been shown in other cancers, such as melanoma and renal cell carcinoma, to eradicate even bulky disease. We are now on a new learning curve with better understanding not only of what it takes to stimulate an immune response but what it takes to reverse the tumor-mediated escape mechanisms present at the actual tumor site. With the accelerated development in this field that has happened over the last few years, we should make good progress in the near future.

*   *   *   *   *  

IMIG 2012: Steven Albelda confirms that immunotherapy is a very promising treatment for mesothelioma.

Dr. Steven Albelda
iMig 2012
No need for explantion here. Dr. Cameron’s succinct appraisal speaks for itself. Good news! I remember years ago when I was a director on MARF feeling proud to help sponsor Dr. Abelda’s futuristic benchwork research. Smart guy. Good guy. Glad Dr. A is on the team.

David Sugarbaker: "Can't we all just get along and operate on mesothelioma?"

Funny question, coming from the Pope of the EPP himself who for years dominate the conversation, owned the paradigm, and didn't give much heed to his few naysayers. Let’s face it, we love a title fight between heavyweights, so I couldn’t resist asking Dr. C for his reaction to the EPP’s loudest and most cocksure advocate sudden plea for tolerance. Is Dr. S presuming that surgery, no matter what form it takes, must be bedrock of every treatment regimen for meso?

Dr. Cameron: Despite the continued lack of randomized prospective trials showing exactly what, if any, benefit that surgery offers, Sugarbaker must be feeling the heat of all the mounting data that EPP is not necessary.  In my view, he’s now trying to deflect that argument and avoid controversy by calling on all surgeons regardless of which operation you perform to tell medical oncologists and pulmonologists that surgery forms the cornerstone of treatment.

*   *   *   *   *  

IMIG 2012: David Sugarbaker admits that "EPP has no superiority" as an operation over pleurectomy and decortication

Dawgies! Is this one of those “Yes, the earth revolves around the sun” belated acknowledgements? So, Dr. C, why is this such a big deal (picture me feeding the tiger a little red meat).

Dr. Cameron:  “You're kidding right? Most of the posters at this meeting were people trying to do EPPs because they are all under the impression that the "data" shows that it is better.  [Which unfortunately means that for too many ‘get her done’ surgeons with yank-the-lung-it is the earth continues to be the center of the universe….].

*   *   *   *   *  

IMIG today: Sugarbaker admitted that he is now doing 2/3 pleurectomies for mesothelioma....a huge change from a few years ago

This is a radical reversal. We asked Dr. C if he knew whether the Titan of Tri-modal had ever publically debunked or disparaged PD for meso?

Dr. Cameron: “I’m not sure he’s ever disparaged the P/D for meso directly but he has said that the only curative operation for the disease was the EPP. “

*   *   *   *   *  

Pac Meso Center’s Presentation: "The timing of chemotherapy in the multimodality treatment of malignant pleural mesothelioma" received praise from IMIG.

Congratulations!  To read the abstract of this presentation (by Dr. Cameron), please click here.

Note, it was great to learn that the other surgeon who helped form MARF back in the day (1999), Dr. Harvey Pass, one of the most talented, gifted and intelligent doctors on the planet, complemented the presentation and agreed that chemotherapy may not be such a crucial part of "trimodality" therapy (patient ALWAYS want to avoid chemo; losing their hair, nausea, vomiting, etc.) Thank you Dr. Harvey Pass, one of my heroes in the topsy-turvy turbulent Mesoworld.

Our Presentation: Percutaneous outpatient cryoablation for localized recurrent pleural mesothelioma was likely the highlight of IMIG meeting

This is great news. My law firm is particularly proud of this since cryoablation has been used successfully on several of my meso clients (including Martha MunozPatricia Crawford and Sylvia Ramirez) who were relieved and impressed with it’s ease, efficiency and results.

The Pacific Meso Center is currently writing two papers that will be published soon. Consequently, since journals won’t publish anything that’s already been publically circulated, the PMC cannot a this time post it’s powerpoint slides on the internet. Dr. Cameron did however reveal, happily, if not surprisingly, that Dr. Sugarbaker mentioned cryoablation specifically as one of the highlights of info being presented. High praise from the High Priest of Meso! And well should the Big Guy be impressed – preliminary data show that the practice for recurrent patients was effective in 95% of the cases.

*   *   *   *   *  

David Sugarbaker TOTALLY BACKS OFF his beloved EPP to "MCR" Macroscopic Complete Resection, which is code for pleurectomy and decortication

We asked Dr. C to flesh out what this means for the typical meso patient. The backstory of course is that Dr. C has always pointed out that total eradication of all tumor is a pipe dream and they only reasonable goal was the removal of all “visible” tumor? (Note to patients – make sure your surgeon is wearing telescopic lens gear).

Dr. Cameron:  Yes, that’s been my common sense approach, but the EPP crowd never embraced this until now. This basically recognizes that what I have said for decades is actually now widely accepted and people like even Dr. Jablons who abandoned P/D for EPP were bowing to peer pressure not acting on data.”

Well, dear readers, hope you enjoyed the ride. It’s been fun. Please drop us a line if you want to learn more. In the meantime, praise hope!


RGW
Sept. 18, 2012
Roger G. Worthington

Monday, September 3, 2012

California Measure Imposing Reasonable Limits on Length of Plaintiff Depositions Moves Closer to Becoming Law!


The Worthington Law Firm has long advocated for reasonable limitations on the length of time that asbestos companies can question asbestos cancer patients. At this time, there is no state-wide rule that limits the amount of time that asbestos company lawyers can question asbestos cancer patients in the context of a pre-trial discovery depositions.

This “anything goes” policy has led to wide-spread abuse. Asbestos company lawyers have typically prolonged depositions well over 20 to 30 hours, over the course of 10 to 15 days – even when the patient’s doctor has warned of the deleterious impact of such interrogation.

Finally, on August 29, 2012, at the urging of plaintiffs attorneys, California lawmakers passed a bill that would impose state-wide limits on the length of plaintiff depositions.  The general rule would limit defense questioning of a plaintiff to seven hours of total testimony. In asbestos illness cases where a physician attests that the plaintiff’s illness raises substantial medical doubt of survival beyond six months, defense questioning would be limited to two days of no more than seven hours of testimony each day, or 14 hours of total testimony.

The Worthington Firm, along with other plaintiffs attorneys, had pushed for a limit of seven hours across the board, or at least for all asbestos cancer cases, similar to the rule that applies in Federal Court and many states such as Texas. While this was rejected by the legislature, we would nevertheless consider this new law just, fair and humane measure to curb abusive and deleterious deposition practices.

Under existing law, asbestos company lawyers are entitled to assume that depositions are limitless. If the new law is passed, 14 hours will be the presumed limit in most cases, with the ability to seek even shorter limits on a case-by-case basis with a doctor’s declaration.

The bill now moves on to Governor Jerry Brown who has not taken a position on the matter. It is hoped that Governor Brown will realize how the absence of California law on this subject has permitted defense attorneys to needlessly and cruelly capitalize on the physical frailties of injured plaintiffs.

We strongly urge Governor Brown to sign the bill into law. 

Governor Brown can be reached online at http://govnews.ca.gov/gov39mail/mail.php, and his mailing address is c/o State Capitol, Suite 1173, Sacramento, CA 95814. We encourage you to drop a note to Gov. Brown urging him to support a bill that will curb deposition abuse.


Wednesday, August 1, 2012

Roger G. Worthington, P.C. – Longtime Supporter Of The Pacific Meso Center – Donates $100,000 For Mesothelioma Research


I am pleased to continue my support of the the "Punch" Worthington Laboratory (PWR Lab) at the David Geffen School of Medicine in honor of my father, David "Punch" Worthington, Ph.D. with a contribution of $100,000.

The PWR Lab is the home of exciting new research on novel strategies for the treatment of mesothelioma and other occupational cancers.

In 2005, I was proud to help launch this vital research effort in honor of Punch who was diagnosed with asbestosis and lung cancer. Punch obtained a Ph.D. in Genetics but left a promising career in academia to pursue his true love: labor union organizing and advocacy. His memory lives on through the efforts of Dr. Robert Cameron and his staff.  Thank you Dr. Cameron!

RGW
July 31, 2012


Tuesday, July 24, 2012

Pacific Meso Center 5K Walk and BBQ - October 14, 2012


In December of 2011, The Pacific Meso Center recently announced the opening of its new state-of-the-art mesothelioma research laboratory.  The lab was dedicated solely to discover new treatments for malignant pleural mesothelioma.  The research laboratory will provide laboratory-to-the-bedside research with a goal to improve mesothelioma victims’ lives and longevity.

On Sunday, October 14th 2012, the PMC is holding their inaugural 5K walk and barbeque to raise awareness about mesothelioma and to pay tribute to those who have fought the disease or are still fighting. All proceeds benefit the PMC’s laboratory at UCLA and PMC’s laboratory on Santa Monica Boulevard.  Click here for more information.

Join us as we, together with the Pacific Meso Center, walk-the-walk and talk-the-talk in finding new and better ways of treating malignant pleural mesothelioma.

Sunday, October 14th 2012
Paramount Ranch
2903 CORNELL RD, Agoura Hills, California 91301
Registration opens 10:00 a.m.
Walk commences 11 a.m. – 12:00 p.m.
BBQ in the old Western Town 12:00 p.m. – 1:30 p.m.

Feel free to contact Clare Cameron at 310-478-4678 or email her at ccameron@phlbi.org

Sunday, July 15, 2012

Tour Des Chutes Raises $125,000 for Cancer Survivorship



TdC emcee Roger Worthington
interviewing Karsten Hagen,
a 43 year old prostate
cancer survivor.
  One year after
his prostatectomy, Mr. Hagen
feels great and has
even improved his performance
in the time trial.
On a brilliant day with alternating sunny blue skies and rumbling thunderstorms, the 8th annual Tour Des Chutes sent a strong message that, when it comes to surviving cancer, you are not alone.

Over 1,400 riders, from 16 states and ranging from age 2 to 93, pinned their numbers on and rode from 8 to 100 miles for somebody they know who has cancer or died from it. It was a picture perfect day, with the majestic snow capped Cascade Mountain Range as the soaring backdrop.  The riders rode with a purpose: as in life, there were moments of reverence, a time to put the head down and grind away, and those special moments when the exuberance could barely be contained.

The TdC has come a long way in a short time. The Pacific Meso Center is proud to be a yellow jersey sponsor for the fourth year in a row. Last year, the TdC raised over $100,000, a record many thought would be tough to break. But this year, thanks to the generous support of sponsors like the PMC, the TdC exceeded expectations by raising over $125,000. 

Since the TdC is an all volunteer effort, the lion share of that net revenue goes directly to a cancer survivorship at the St. Charles Medical Center in Bend, Oregon. St. Charles provides cancer treatment as well as a bevy of useful support programs for both patients and their loved ones.  A few of the these programs include a monthly DEFEAT cancer dinner, a Young Adult Survivor Network (age 18-40), the Soaring Spirits Camp (a fun retreat for children at nearby Suttle Lake), Nurse Navigators, Cancer and the Arts, and the Support Sisters and Brothers network, a mentorship program that matches one year survivor "veterans" with newly diagnosed patients.

Every finisher was greeted by a
 throng of supporters who
jubiliantly clanged their cowbells.
Cancer survivors got a special
treat - a beautiful yellow
rose. Over 100 of the
1400 participants were
cancer survivors.
On a day filled with joy, laughter, music, food and good old fashioned exercise induced salty sweat, there was unfortunately one dark cloud. The man who hatched the idea at his kitchen table with a few friends in 2004, Gary Bonacker, himself a brain tumor survivor, was forced to sit this years' event out. Gary was struck by a seizure a few days earlier and hospitalized.  Dozens of friends wore a picture of Gary on their jersey to show their love and support for this incredibly strong, resilient and inspiring pillar of the community.  We wish him (another) speedy recovery.

The organizers have reason to feel optimistic. The trend is upward and to the right. Ridership is up. The volunteer army is swelling. The organization gets crisper every year. The food and beverages are always top notch, as are the musicians who provide the upbeat entertainment. Several titans from the medical and pharmaceutical worlds have taken notice of this up and coming fundraiser in Central Oregon.  Next year, we hope we can report not only more riders, but also more sponsorship money.  None of it would be possible without the leadership of Gary and his devoted crew of directors and volunteers.  

Thanks to everybody who helped make the 8th Annual Tour Des Chutes the best one ever.

Cheers!
  
RGW
7/15/2012

Monday, June 11, 2012

A Tribute to a Meso Patient Champion: Pastor Thurl Charles Van Kirk

Pastor Thurl Charles Van Kirk
Although the odds were always stacked against him, Pastor Thurl Charles Van Kirk defied the survival statistics for mesothelioma. He fought a courageous battle for four and a half years before passing away on May 25, 2012. In 2008, he was diagnosed with biphasic mesothelioma, an aggressive form of mesothelioma which is typically considered to be inoperable. Under the direction of UCLA surgical oncologist Dr. Robert Cameron, Pastor Van Kirk underwent an experimental chemotherapy regimen. Although the side effects were grueling at times, the chemotherapy proved to be effective in eradicating the inoperable constituents of the tumors. Pastor Van Kirk was then able to undergo a lung-sparing pleurectomy /decortication surgery with Dr. Robert Cameron in September 2008.

Through the years, Pastor Van Kirk enjoyed a remarkable period of no tumor recurrence. But like many cancer patients, his experiences were not without their share of uncertainties and concerns. He beat the odds statistically and attributed his success to the innovative treatment approaches of Dr. Cameron and the UCLA Comprehensive Mesothelioma Program.

According to Pastor Van Kirk, "There are all kinds of miracles. Mine happened to be the kind that comes from great science, lucky timing, and the best mesothelioma doctors on the West Coast."

Much loved by his community and parishioners, Pastor Van Kirk served as senior pastor of the Rim of the World Community Church from 1985 until he retired in 2010. He and his wife Diane raised their three daughters in the mountain community of Running Springs. Pastor Van Kirk was interred with military honors at the Riverside National Cemetery. The service was unsurprisingly well-attended by Pastor Van Kirk’s family, friends and community, a testament to a man who lived his life and led his congregation by example and the positive influence he had on others. The words shared by those in attendance conveyed the profound love and respect for Pastor Van Kirk and the chasm he leaves behind in their hearts.


Riding with Pastor Chuck in his beautiful Shelby GT
I was blessed to have had the privilege of representing Pastor Van Kirk and getting to know what an extraordinary person he was. I will always remember his infectious laugh and thoughtful and generous nature. He proved to be a tremendous source of information and inspiration for countless newly-diagnosed patients who were struggling to cope with their illness
.
A couple years ago, Pastor Van Kirk shared the following with me:

Yes, attitude is everything.  At times my hardest struggle is just to get up in the morning.  Deep, throbbing pain in my side demands attention.  So I pop some pain meds and lay back down pondering what heaven will be like when we receive new bodies that never break down, get sick, wrestle with illness or suffer! 

Pastor Chuck, while I share with so many others in the sadness of your loss, it brings a smile to my face to know that you will be enjoying an eternity of skiing, hiking, woodworking and hot-rodding in your Shelby convertible in your new body!

John Caron
June 11, 2012

Monday, June 4, 2012

UCLA Mesothelioma Care Employs Lung-sparing Surgery and Unique Treatment Approach


UCLA’s Mesothelioma treatment program focuses on research and experience and has pioneered the use of therapies, such as immunotherapy and cryoablation which have led to significant advances in care. At UCLA, basic science and clinical research have suggested some unique approaches that are helping to make inroads in the management of mesothelioma.

“UCLA has developed a program to treat these unusual tumors — including the very rare sarcomatoid type — that centers on lung-sparing surgery and treating the disease as a chronic illness, focusing on treatments that improve our patients’ quality of life,” explains Robert B. Cameron, M.D., FACS, professor and director of UCLA’s Comprehensive Mesothelioma Program.

About 15 percent of mesothelioma cases are of the sarcomatoid type, which tends to be both invasive and metastatic. As a rule, surgeons will not operate on these patients as the cancer is difficult to remove and the  patients have not typically fared well with any treatments.  Click here to learn more.